The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Open accessAbstract
Susceptibility to systemic meningococcal disease is related to a selective deficiency of humoral antibodies to pathogenic strains of meningococci. In a study of the age-specific incidence of meningococcal meningitis in the United States, it was found that the proportion of individuals with serum bactericidal activity to meningococci of serogroups A, B, and C was reciprocally related to the incidence of disease. The prevalence of bactericidal activity was highest at birth and among adults, and lowest in infants between 6 and 24 months of age. Sera from 51 of 54 prospective cases of meningococcal disease among military recruits were deficient in antibodies to homologous and heterologous strains of pathogenic meningococci as determined by serum bactericidal activity and indirect immunofluorescence. Such sera, however, could support the bactericidal activity of purified human gamma globulin (Cohn fraction II), and such individuals could respond immunologically to infection with meningococci. The implication is that susceptible persons are deficient in antimeningococcal antibodies because they have not received significant exposure to meningococcal antigens in the past. The fate of individuals who lack bactericidal antibodies to pathogenic meningococci was determined during an outbreak of group C meningitis among military recruits. The incidence of disease was found to be primarily associated with the incidence of exposure of susceptibles to the pathogenic strains. Whereas 81.5% of the presumed susceptibles acquired a meningococcal strain, only 24.1% acquired an organism similar to the prevalent disease-producing strains. Of the exposed susceptibles, 38.5% developed systemic meningococcal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES
Dulbecco, R., & Vogt, M. (1954) · Journal of Experimental Medicine · doi:10.1084/jem.99.2.167 · Cited by 3,824
Handbook of Experimental Immunology.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1376_1 · Cited by 2,408
Eichorn, D. H., & McNemar, Q. (1956) · The American Journal of Psychology · doi:10.2307/1419072 · Cited by 370
Fothergill, L. D., & Wright, J. (1933) · The Journal of Immunology · Cited by 334
McNemar, Q. (1949) · Bibliothèque et Archives nationales du Québec (Québec government) · Cited by 227
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1385 · Cited by 199
Self-citationTHE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 176
Purulent Meningitis of Newborn Infants: Eleven-Year Experience in the Antibiotic Era
Groover, R. V., Sutherland, J. M., & Landing, B. H. (1961) · New England Journal of Medicine · doi:10.1056/nejm196106012642201 · Cited by 137
THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS)
Branham, S. E. (1940) · Bacteriological Reviews · doi:10.1128/br.4.2.59-96.1940 · Cited by 29
Cited by
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,169
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Self-citationEpidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
Finne, J., Leinonen, M., & Mäkelä, P. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90340-9 · Cited by 796
Li, S., Rouphael, N., Duraisingham, S., Romero-Steiner, S., Presnell, S., Davis, C., Schmidt, D. S., Johnson, S. E., Milton, A., Rajam, G., et al. (2014) · Nature Immunology · doi:10.1038/ni.2789 · Cited by 770
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Infectious diseases associated with complement deficiencies
Figueroa, J. E., & Densen, P. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.3.359 · Cited by 729
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Shankar, G., Devanarayan, V., Amaravadi, L., Barrett, Y. C., Bowsher, R., Finco-Kent, D., Fiscella, M., Gorovits, B., Kirschner, S., Moxness, M., et al. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.020 · Cited by 613
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Robbins, J. B., Austrian, R., Lee, C. J., Rastogi, S. C., Schiffman, G., Henrichsen, J., Makela, P. H., Broome, C. V., Facklam, R. R., Tiesjema, R. H., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1136 · Cited by 564
Miller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Escherichia coli K1 Capsular Polysaccharide Associated with Neonatal Meningitis
Robbins, J. B., McCracken, G. H., Gotschlich, E. C., Ørskov, F., Ørskov, I., & Hanson, L. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197405302902202 · Cited by 457
Self-citationAcute bacterial meningitis in infants and children
Kim, K. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70306-8 · Cited by 454
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
Self-citationNeisseria meningitidis: Biology, Microbiology, and Epidemiology
Rouphael, N. G., & Stephens, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-346-2_1 · Cited by 425
Maslanka, S. E., Gheesling, L. L., Libutti, D. E., Donaldson, K. B., Harakeh, H. S., Dykes, J. K., Arhin, F. F., Devi, S. J., Frasch, C. E., Huang, J. C., et al. (1997) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.4.2.156-167.1997 · Cited by 420
Meningococcal surrogates of protection?serum bactericidal antibody activity
BORROW, R., BALMER, P., & MILLER, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.051 · Cited by 413
Holst, J., Martin, D., Arnold, R., Huergo, C. C., Oster, P., O’Hallahan, J., & Rosenqvist, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.071 · Cited by 405
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1367 · Cited by 402
Self-citationMeningococcal Disease: Still with Us
Peltola, H. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.71 · Cited by 394
Madico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.501 · Cited by 390
Robbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
Tappero, J. W., Lagos, R., Maldonado Ballesteros, A., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L. L., Carlone, G. M., Høiby, E. A., Holst, J., et al. (1999) · JAMA · doi:10.1001/jama.281.16.1520 · Cited by 369
Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine
Artenstein, M. S., Gold, R., Zimmerly, J. G., Wyle, F. A., Schneider, H., & Harkins, C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197002192820803 · Cited by 369
Self-citationMurphy, T. F., & Apicella, M. A. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.1.1 · Cited by 324
Andrews, N., Borrow, R., & Miller, E. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.780-786.2003 · Cited by 323
Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children
Gold, R., Goldschneider, I., Lepow, M. L., Draper, T. F., & Randolph, M. (1978) · Journal of Infectious Diseases · doi:10.1093/infdis/137.2.112 · Cited by 322
Self-citationMbaeyi, S. A., Bozio, C. H., Duffy, J., Rubin, L. G., Hariri, S., Stephens, D. S., & MacNeil, J. R. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6909a1 · Cited by 321
Borrow, R., Andrews, N., Goldblatt, D., & Miller, E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1568-1573.2001 · Cited by 316
Donnelly, J., Medini, D., Boccadifuoco, G., Biolchi, A., Ward, J., Frasch, C., Moxon, E. R., Stella, M., Comanducci, M., Bambini, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013758107 · Cited by 297
Human Serum Activities against Hemophilus influenzae, Type b
Anderson, P., Johnston, R. B., & Smith, D. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106793 · Cited by 277
Glycointeractions in bacterial pathogenesis
Poole, J., Day, C. J., von Itzstein, M., Paton, J. C., & Jennings, M. P. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0007-2 · Cited by 271
Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168
Prevention of Meningococcal Disease
Gardner, P. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp063561 · Cited by 140
Kelly, D. F., Pollard, A. J., & Moxon, E. R. (2005) · JAMA · doi:10.1001/jama.294.23.3019 · Cited by 113
Oftung, F., Løvik, M., Andersen, S. R., Frøholm, L. O., & Bjune, G. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01374.x · Cited by 21
Metadata
- Authors
- Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1969-06-01
- Volume
- 129
- Issue
- 6
- Pages
- 1307-1326
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2115350923
- Cited by
- 1,294
- References
- 9
- FWCI
- 22.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.